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HYNDA K. KLEINMAN, PH.D., J. CLIFFORD MURRAY, PH.D., ERMONA B. MCGOODWIN, B.S., 
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Established lines of fibroblasts have been shown to 
adhere to collagen substrates via a serum-derived gly-
coprotein. The attachment of various other cells to col-
lagen types I-IV is examined here. Cells such as human 
skin fibroblasts, periosteum, hepatocytes, connective tis-
sue cells, and monocytes required the serum glycopro-
tein and adhered equally well to all collagens, but at-
tachment of chondrocytes, epidermal cells, and neutro-
phils was inhibited by the serum glycoprotein. Attach-
ment of 2 tumorigenic cells, an osteosarcoma and a fi-
brosarcoma, was found to be unaffected by the serum 
glycoprotein. In addition, the fibrosarcoma and epider-
mal cells attached preferentially to type IV (basement 
membrane) collagen. 
Recent studies have begun to explain the molecular mecha-
nisms underlying cell-matrix interactions. Collagen is recog-
nized as a major structural protein and the major protein 
constituent of most extracellular matrices. Miller and Matukas 
[1] discovered that cartilage contains a different type of collagen 
from that present in tendon, bone, skin, etc. Subsequently, 
other collagens have been discovered [2-5]. Some of these 
proteins [6,7], including 2 nonstructural ones, and theil' loca-
tions are presented in Table 1. These collagens are usually 
found in different tissues. For example, type II collagen is 
largely lilni ted to cartilage [1] and type IV to basement mem-
brane [3]. Type I and type III collagens, which are often found 
in the same tissue ,[2], can be synthesized by the same cell [8], 
but usually they are found in sepa.rate fibers [9]. The tissue 
distribution of type V collagen has not been established. 
Current findings suggest that the various collagens define 
unique matrices with widely different physical properties. Ten-
don is a highly ordered, l'opelike material that has type I 
collagen as its major component. Cartilage contains type II 
collagen and substantial amounts of proteoglycan and water. 
Cartilage collagen is more like a cushion than a rope. Type III 
collagen is usually associated with highly extensible tissues such 
as blood vessels and intestine. Basement membranes are rich in 
glycoproteins as well as in type IV collagen. CIq and acetylcho-
linesterase are not found in fibrous structW'es, and the roles of 
these collagens have not been established. 
CELL ATTACHMENT TO COLLAGEN 
There is evidence that collagens can help cell growth, differ-
entiation, sW'vival in vitro, and presumably in vivo. Although 
cell biologists have used collagen as a substrate for cells for 
many years, the way in which collagen or other substrates 
supports cell maintenance is not clear. In 1974, Klebe reported 
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AGF: antigelatin factol' 
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CIG: cold insoluble globulin 
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that without a serum protein cells do not attach dil'ectly to 
collagen [10]. In Klebe's studies, CHO cells were plated onto 
plastic Petri dishes (bacteriological rather than tissue cultW'e) 
coated with collagen. In 1.5 hI' little 01' no attachment of CHO 
cells was observed unless serum was present. Collagen sub-
strates exposed to serum were washed, and they subsequently 
bound cells. In the absence of collagen, cells exposed to collagen 
cell attachment protein [c-CAP] did not attach to collagen. 
Klebe partially pW'ified the c-CAP from serum and found that 
it is a large protein that binds to collagen tenaciously. His 
studies also showed that CHO as well as other cells can synthe-
size c-CAP but that the protein is destroyed by trypsin. At least 
1 hr was requil'ed for the cells to resynthesize and transport c-
CAP to theil' surfaces. 
Other investigators have also studied the occW'rence and 
function of glycoproteins bound to the sW'faces of cells. Weston 
and Hendricks [11] observed reduced contact inhibition of ' 
movement and growth in cells treated with W'ea in a low 
concentration. A non dialyzable factor in the extract restored 
normal contact inhibition. The factor appeared to be a protein, 
i.e., it was inactivated by heat and trypsin. Subsequently, this 
Type I 
Type II 
Type III 
Type IV 
Type V 
CIq 
Acetylcholines-
terase 
TABLE I. The collagells 
Chain composition 
[al(I)ha2 
[al(lI)h 
[a l(II!)), 
[proal (IV)]:J 
aA, aBo 
(A, B, C)G 
? 
Location 
Skin, bone, tendon 
Cru·tilage 
Blood vessels, skin, spleen 
Basement membrane 
Placenta, smooth muscle 
Serum 
Synapses 
" Chain composition has not been established. 
factor was identified as a la.rge (440,000 daltons) surface-asso-
ciated glycoprotein [12]. Several other groups have studied 
silnilar proteins present on cell surfaces, in culture medium, 
and in serum [12-15]. The proteins are present in greatly 
reduced amounts in transformed cells [13,14]. This family of 
proteins is known by a variety of acronyms, including LETS 
(large external transformation-sensitive) protein, CSP (cell SW'-
face protein), CIG (cold insoluble globulin) , and AGF (anti-
gelatin factor) . Rouslahti and Vaheri proposed that these pro-
teins are identical and suggested that they be named fibronectin 
[16]. Dessau et al [17] found that AGF and CIG are silnilar in 
size, subunit size, composition, and the manner in which they 
react with antibody. Pearlstein [18] repeated some of Klebe's 
studies [10] on cell attachment to collagen and proposed that 
CSP and c-CAP are the same protein. Kleinman et a] [19] 
found that CSP and CIG attach CHO cells to collagen-coated 
dishes in the absence of serum. 
In immunofluorescence studies the distribution of collagen 
and LETS protein on the cell surface often appear similar 
[20]. It is likely however that LETS protein is both a peripheral 
membrane component and a constituent of the extracellular 
matrix. 
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TABLE II. A ttachment Properties of Cells 
Cell type 
CHO 
31'3, SV -31'3, Ki-3T3 
Human skin fibroblasts" 
Rat hepatocytes b 
Mouse connective tissue c 
Rat embryo periosteum d 
Guinea pig epidermal epithe-
lium " 
Substra te preferred 
Collagen I-IV 
Collagen I-IV 
Collagen I-IV 
Collagen I-IV 
Collagen I- IV 
Collagen I- IV 
Collagen IV 
Chondrocytes t Collagen I- IV 
High metastatic murine fi - Collagen IV 
brosarcoma (1'241) C 
Osteosarcoma (type R-3559- Collagen I-IV 
52) <1 
MonocytesH Plastic, collagen 
NeutrophilsH Plastic, collagen 
" American Type Culture # 1106, 1220. 
b M. Berman, unpublished observations. 
C J . C. Murray and L. Liotta, personal observations. 
Serum required 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Inhibited 
Inhibited 
No effect 
No effect 
Yes 
Inhibited 
d J. C. Murray and I. Binderman, personal observations. 
• J. C. Murray, G. Stingl, and S. Katz, personal observations. 
t H . K. Kleinman and J. P. Pennypacker, personal observations. 
H H. K. Kleinr~an and E. Schiffmann, personal observations. 
NATURE OF THE BINDING SITE IN COLLAGEN 
The studies of Kleinman, McGoodwin, and Klebe [21], Klein-
man et al* and Dessau et al [22] were designed to identify the 
portion of collagen that reacts with c-CAP. These studies 
showed that both native and denatmed collagen can bind c-
CAP. They found a major binding site in al(I)-CB7, a peptide 
of about 25,000 daltons produced from the a l(I) chain by 
digestion with CNBr. Now Kleinman et a1. * have produced a 
variety of peptides from the al(I) chain; they have found that 
the binding site lies between residues 757 and 791 of the a l(I) 
chain . This peptide sequence lacks carbohydrate, is triple heli-
cal in the collagen molecule, and contains a hydrophobic-rich 
and proline-poor sequence. Previous studies showed that the 
single peptide bond cleaved by animal collagenases lies between 
residues 775 a nd 776. Cleaving this bond destroys the ability to 
bind to c-CAP. 
ATTACHMENT TO DIFFERENT COLLAGENS 
We examined the binding of various cell types to collagen 
and other substrates (Table II). These studies tested the affinity 
of the various cells to 4 types of collagen (types I, II, III, and 
IV) as well as t he effect of sermn on the binding of cells to 
coUagen. The results showed that various fibroblast-like cells, 
including CHO, 3T3, and human fibroblasts, as well as hepa-
tocytes and periosteal cells, require serum to attach to collagen 
and show an equal preference for types I through IV. Epidermal 
epithelial cells from guinea pig skin bind best to type IV 
collagen, and their attachment is inhibited when serum is 
added. Attachment of these cells is slow and may be dependent 
on t he synth esis of a specific c-CAP by these cells. A preference 
for type IV collagen would be expected from the association of 
these cells with basement membrane in vivo. The a ttachment 
of chondrocytes to collagen is also inhibited by serum, but 
chondrocytes show no preference for one collagen over another. 
At present, our studies suggest that chondrocytes produce still 
anoth er c-CAP. Serum is presumed to inhibit binding because 
c-CAP competes for the sam e site on collagen as the chondro-
cyte factor. 
Some differences have been noted in the attachment of cells 
obtained from 2 solid tumors (T241 and R3556). Cultmed cells 
from a highly m etastatic tumor, fibrosarcoma T 241 [23], show 
a preference for type IV collagen , whereas fibroblasts bind 
• Kleinman, HK, McGoodwin EB, Martin GR, Klebe RJ, Fietzek 
PP, Woolley DE: Localization of the binding site for cell attachment in 
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equally to types I through IV. Cells from an osteosarcoma 
[24], a nonmetastatic tumor, show no preference. Serum neither 
promotes nor inhibits the attachment of either kind of tumor 
cell. It is possible that the affinity of these transformed cells for 
different collagen types influences their ability to metastasize 
since the metastatic tumor cells adhere best to type IV collagen 
and the nonmetastatic tumor cells show no preference. 
A different pattern of attachment occurs with monocytes and 
neutrophils. These cells attach well to bacteriological dishes, to 
types I through IV, and even to Ascaris collagen, which fails to 
support fibroblast attachment. Serum, which is required for the 
attachment of monocytes to collagen, inhibits the attachment 
of neutrophils. Clearly these cells have additional modes of 
attaching to substrates. 
The attachment of many cells to collagen occw'S through 
various related proteins present in serum or produced by the 
cells. In the case of fibroblasts, these proteins appear to bind at 
or between residues 757 and 791 of the a1(I) chain. In vitro cell 
studies indicate there is a preference for one collagen over 
another. Since attachment of chondrocytes and epithelial cells 
is inhibited by serum, different attachment proteins may occm 
for these cells. The association of certain cells with a particular 
matrix may be determined by the interaction of a particular 
collagen species in the matrix with a specific c-CAP that binds 
to unique determinants on the cell surface. 
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